Founded in 1863, Bayer is a 45 billion EUR giant with three businesses: pharmaceuticals; consumer health products; and crop sciences, a division devoted to fertilizers, seeds, and other products.
As ongoing digital transformation creates massive changes and opportunities for the Life Science industry, Bayer is seeking to develop new life science solutions based on digital technology, machine learning, sensors, and new business models, as well as define faster, less-costly development, testing, and go-to-market processes and solutions.
In 2015, Bayer established its Bayer iHUB lab, embedded at the Singularity University (SU) campus in Mountain View, CA, to capitalize on the different mindset and the technological innovation for which Silicon Valley is famous. The iHUB’s focus is on digital innovations in the life sciences space and incorporates emerging or exponential technologies into its research.
Read this case study to find out how Bayer is working with SU and the SU global innovation ecosystem to understand exponential technologies, trends, and business models, and how this approach has helped the company introduce new, innovative projects and form uncommon partnerships.
At Singularity University, we elevate exceptional companies into exponential enterprises that can thrive amid chaos and uncertainty, and we provide the tools, frameworks, and leadership models to help you future-proof your organization.
See how we can help transform your organization into an exponential enterprise with leaders who are prepared to tackle the coming changes and seize new opportunities.
Learn more about the SU programs featured in the case study:
“The iHUB is a place to innovate, to experiment and to iterate fast on promising discoveries. The Silicon Valley environment, which often times feels like a big village, helps tremendously to keep the fast pace. It’s just a perfect place full of smart, excited, high energy, and a bit crazy people. It’s also a lot of fun and the team loves to be part of it. ”— Dirk Schapeler, iHUB’s VP Digital Innovation US, Bayer